Skip to main content
. Author manuscript; available in PMC: 2015 Nov 11.
Published in final edited form as: Bioconjug Chem. 2014 Nov 24;25(12):2197–2204. doi: 10.1021/bc500415x

Figure 5.

Figure 5

Biodistribution of 44Sc-CHX-A″-DTPA-Cetuximab-Fab in U87MG tumor bearing mice (targeted), of 44Sc-CHX-A″-DTPA-Cetuximab-Fab in U87MG tumor bearing mice after treatment with a blocking dose of Cetuximab (blocking) and of 44Sc-CHX-A″-DTPA-Cetuximab-Fab in Caco-2 tumor bearing mice (negative control), at 6 h p.i. (n=3).